CryoCath Technologies Inc. — Investor Relations & Filings

CryoCath Technologies Inc. was a medical device company specializing in the development, manufacture, and commercialization of proprietary catheter-based cryotherapy technology. The company focused on delivering controlled cryo energy for minimally invasive procedures, primarily targeting the treatment of cardiac arrhythmias and other obstructions in the body. CryoCath's core product line included cryoablation catheter systems, such as the flagship Arctic Front cryo-balloon catheter. This system utilizes a refrigerant delivered through an inflatable balloon to freeze and disable unwanted electrical circuits in the heart. Recognized as a world leader in cryocatheters, CryoCath Technologies Inc. was acquired by Medtronic Inc., under which its advanced cryoablation solutions continue to be developed and marketed.